Campbell Murray, MD

Dr. Campbell Murray is a seasoned biotech investor, operator, and physician with over two decades of experience in venture capital, biotechnology leadership, and clinical medicine. As Co-founder and Managing Partner of Double Point Ventures, he leads investments in breakthrough life sciences companies, shaping their trajectory from inception to commercialization. Previously, he was a Senior Partner at Bioluminescence Ventures, General Partner at Agent Capital, and Managing Director at Novartis Venture Fund, where he has cumulatively deployed over $500 million into biotech startups, driving multiple IPOs and M&A exits. Beyond investing, Dr. Murray has held leadership roles at Diabetes Free and Intima Bioscience and has served on 25 biotech company boards. His expertise spans company creation, early-stage and growth capital investing, and corporate strategy, with a focus on advancing groundbreaking innovations in biotechnology.